Precision Biomed Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.59 Cr
as on 10-12-2024
- Satisfied Charges ₹ 3.46 Cr
as on 10-12-2024
- Revenue 37.33%
(FY 2022)
- Profit 791.09%
(FY 2022)
- Ebitda 233.09%
(FY 2022)
- Net Worth 90.56%
(FY 2022)
- Total Assets 17.90%
(FY 2022)
About Precision Biomed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.59 Cr. The company has closed loans amounting to ₹3.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Shekhawat and Priya serve as directors at the Company.
- CIN/LLPIN
U24232RJ2014PTC045131
- Company No.
045131
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Precision Biomed Private Limited offer?
Precision Biomed Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Volumetric Pipette, Medical Laboratory Instruments, Rapid Test Kit, HCV Test Kit, Diagnostic Test Kit, Biochemistry Analyzer, Blood Group Test Kit, Malaria Test Kits, Syphilis Test Kits.
Who are the key members and board of directors at Precision Biomed?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Shekhawat  | Director | 17-Feb-2014 | Current |
| Priya | Director | 17-Feb-2014 | Current |
Financial Performance of Precision Biomed.
Precision Biomed Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.33% increase. The company also saw a substantial improvement in profitability, with a 791.09% increase in profit. The company's net worth Soared by an impressive increase of 90.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Precision Biomed?
Unlock access to Precision Biomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Aug 2023 | ₹1.05 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Oct 2020 | ₹2.10 M | Open |
Sidbi Creation Date: 13 May 2020 | ₹3.30 M | Open |
How Many Employees Work at Precision Biomed?
Precision Biomed has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Precision Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Precision Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
